Release Date: 12/07/19 08:22 Summary: High-grade results flag more Bombora growth Price Sensitive: Yes Download Document 4.61MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%